Xanthine oxidase activity in patients with age-related cataract associated with hypertension

Bojana Kisić1, D. Mirić1, Lepša Žorić2, Julijana Rašić3, R Grbić4, Ljiljana Popović5, A.M. Arsic6
1Institute of Biochemistry, Faculty of Medicine, University of Pristina, Kosovska Mitrovica, Serbia
2Clinic for Eye Diseases, Faculty of Medicine, University of Pristina, Kosovska Mitrovica, Serbia
3Institute of Pharmacology, Faculty of Medicine, University of Pristina, Kosovska Mitrovica, Serbia
4Clinic for General and Orthopedics Surgery, Faculty of Medicine, University of Pristina, Kosovska Mitrovica, Serbia
5Institute of Pathophysiology, Faculty of Medicine, University of Pristina, Kosovska Mitrovica, Serbia
6Department for Laboratory Investigation, Railway Health Care Institute, Novi Sad, Serbia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kisic B, 2012, Role of lipid peroxidation in the pathogenesis of age-related cataract, 457

Chang JR, 2011, Risk factors associated with incident cataracts and cataract surgery in the Age-Related Eye Disease Study (ARDES). ARDES Report No. 32, Ophthalmology, 118, 2113, 10.1016/j.ophtha.2011.03.032

Yu X, 2014, Hypertension and risk of cataract: A meta-analysis, PLoS One, 9, e114012, 10.1371/journal.pone.0114012

Touyz RM, 2004, Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?, Hypertension, 44, 248, 10.1161/01.HYP.0000138070.47616.9d

DeLano FA, 2006, Microvascular display of xanthine oxidase and NADPH oxidase in the spontaneously hypertensive rat, Microcirculation, 13, 551, 10.1080/10739680600885152

Pandey NR, 2000, Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction, Int J Cardiol, 76, 33, 10.1016/S0167-5273(00)00344-2

Suzuki H, 1998, Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats, Proc Natl Acad Sci U S A, 95, 4754, 10.1073/pnas.95.8.4754

Newaz MA, 1996, Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects, Clin Exp Hypertens, 18, 1035, 10.3109/10641969609081033

Miric DJ, 2013, Xanthine oxidase and lens oxidative stress markers in diabetic and senile cataract patients, J Diabet Complicat, 27, 171, 10.1016/j.jdiacomp.2012.09.005

Ledwozyw A, 1986, The relationship between plasma triglicerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis, Clin Chim Acta, 155, 275, 10.1016/0009-8981(86)90247-0

Tsuchida M, 1985, Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation, Biochim Biophys Acta, 834, 196, 10.1016/0005-2760(85)90156-0

Roussos GG, 1967, Xanthine oxidase from bovine small intestine, Methods Enzymol, 12, 5, 10.1016/S0076-6879(67)12005-3

Metcalf JA, 1986, Myeloperoxidase functional assays, 150

Misra HP, 1972, The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, J Biol Chem, 247, 3170, 10.1016/S0021-9258(19)45228-9

Chin PTY, 1976, Purification of rat lung soluble glutathione peroxidase, Biochem Biophys Acta, 445, 558

Jocelyn PC, 1987, Spectrophotometric assay of tiols, Methods Enzymol, 143, 44, 10.1016/0076-6879(87)43013-9

Benzie IF, 1996, The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay, Anal Biochem, 239, 70, 10.1006/abio.1996.0292

Redón J, 2003, Antioxidant activities and oxidative stress byproducts in human hypertension, Hypertension, 41, 1096, 10.1161/01.HYP.0000068370.21009.38

Rodrigo R, 2007, Relationship between oxidative stress and essential hypertension, Hypertens Res, 30, 1159, 10.1291/hypres.30.1159

Dinh QN, 2014, Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension, Biol Med Res Int

Khan SA, 2016, Hypertension potentiates cataractogenesis in rat eye through modulation of oxidative stress and electrolyte homeostasis, J Curr Ophthalmol, 28, 123, 10.1016/j.joco.2016.05.001

Sreeja S, 2015, Status of enzymatic antioxidants in eye lens extracted from cataractous subjects, Int J Pharm Pharm Sci, 7, 139

Rybka J, 2011, Glutathione-related antioxidant defense system in elderly patients treated for hypertension, Cardiovasc Toxicol, 11, 1, 10.1007/s12012-010-9096-5

Cosić V, 2001, Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients?, Clin Chem Lab Med, 39, 818, 10.1515/CCLM.2001.135

Desco MC, 2002, Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol, Diabetes, 51, 1118, 10.2337/diabetes.51.4.1118

Newaz MA, 1996, Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects, Clin Exp Hypertens, 18, 1035, 10.3109/10641969609081033

Feig DI, 2008, Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial, JAMA, 300, 924, 10.1001/jama.300.8.924

Ohara Y, 1993, Hypercholesterolemia increases endothelial superoxide anion production, J Clin Invest, 91, 2546, 10.1172/JCI116491

White CR, 1996, Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits, Proc Natl Acad Sci U S A, 93, 8745, 10.1073/pnas.93.16.8745

Batteli MG, 2014, Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress, Atherosclerosis, 237, 562, 10.1016/j.atherosclerosis.2014.10.006

Van der Zwan LP, 2010, Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure, Hypertension, 55, 1366, 10.1161/HYPERTENSIONAHA.109.147231

Davies MJ, 2011, Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention, J Clin Biochem Nutr, 48, 8, 10.3164/jcbn.11-006FR

Panasenko OM, 1997, The mechanism of hypochlorite-induced lipid peroxidation, BioFactors, 6, 181, 10.1002/biof.5520060212